
Robert F. Kennedy Jr. is escalating his campaign against what he calls America's culture of 'overmedication,' this time turning directly toward antidepressants and psychiatric drugs. The move is already unsettling psychiatrists who fear the administration's rhetoric risks blurring the line between legitimate concerns about prescribing practices and public distrust of mental healthcare itself.
Speaking at a MAHA Institute summit focused on mental health and what organisers described as 'overmedicalisation,' Kennedy announced a federal initiative aimed at reducing what he characterised as excessive psychiatric prescribing, particularly involving children.